|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 165.38 USD | +0.58% |
|
-7.25% | -6.03% |
| 01-20 | Global drugmakers rush to boost US presence as tariff threat looms | RE |
| 01-20 | RBC Trims Price Target on Biogen to $217 From $220, Keeps Outperform Rating | MT |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | Varia. Jan 1. | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BIOGEN INC. | Biopharmaceuticals | +0.58% | -7.25% | -6.03% | +17.67% | -38.81% | 24.26B |  |  | |
- Stock Market
- Equities
- BIIB Stock
- Charts Biogen Inc.
- Relative Strength Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition